openPR Logo
Press release

Tinea Versicolor Treatment Market Projected to Grow Radiantly By 2023 | Industry Growth Influencer - Astellas Pharma , Inc. , Bayer AG , Enzon Pharmaceuticals, Inc. , Galderma S.A., Gilead, Novartis AG , Pfizer Inc.

10-18-2018 12:00 PM CET | Health & Medicine

Press release from: Market Research Future

Tinea Versicolor Treatment Market Projected to Grow Radiantly

A Broad Analysis of the "Worldwide Salivary gland infection market “methodology of the leading organizations in the exactness of import/export utilization, market activity figures, cost, value, revenue and gross edges.

Tinea Versicolor Treatment Market -Overview

Tinea Versicolor is one of the common types of skin infection. It also called as pityriasis versicolor. In this condition, small and discolored patches of skin occur, mostly affecting the shoulders and trunk.

Increasing prevalence of tinea versicolor, increasing awareness of the disease, rising healthcare expenditure, advanced diagnosis and treatment options, and approval of new antifungal medicines are leading the growth of global tinea versicolor treatment market.

Global tinea versicolor treatment market is expected to grow at the CAGR of ~7.1% during the forecast period and is estimated to reach USD 197.9 million by 2023.

Tinea Versicolor Treatment Market -Market Segments

Global tinea versicolor treatment market has been segmented on the basis of diagnosis which comprise physical exam, imaging tests, and others. Imaging test is sub-segmented into wood lamp (black light) examination, microscopy using potassium hydroxide (KOH), fungal culture, skin biopsy, and others. Skin biopsy is sub-segmented into shave biopsy, punch biopsy, excisional biopsy, and others.

On the basis of treatments, the market has been segmented into antifungal shampoos, antifungal creams, drugs, and others. Antifungal shampoos are sub-segmented into selenium sulfide (selsun) 2.5 percent shampoo, ciclopirox (loprox, penlac) shampoo, ketoconazole (ketoconazole, nizoral, others) shampoo, and others. Antifungal creams are sub-segmented into Selenium sulfide (Selsun) 2.5 percent lotion, Ciclopirox (Loprox, Penlac) cream or gel, Ketoconazole (Ketoconazole, Nizoral, others) cream or gel, and others. Drugs are further sub-segmented into fluconazole (diflucan) tablets or oral solution, and others.

Get PDF with Technological Advancement @ https://www.marketresearchfuture.com/sample_request/3878

Tinea Versicolor Treatment Market -Key developments

Major players in the market are engaged in the development of new products to capture the market globally. Thus, key market players are investing more in research and development activity, in order to lead the global market. In this regards, market players undertake various strategic approaches.

In March 2016, Novartis cancer drug gets FDA's principal 'biosimilar' affirmation. Federal regulators have permitted the first “biosimilar” drug to be sold in the U.S. under a program intended to branch a new market of lower-cost substitutes to some of the most expensive treatments in healthcare.

In May 2016, Novartis studies new sales model for tentative cancer therapy. Novartis strategies to use a medical device-like sales model to market its CAR T-cell technology if the new cancer treatment receives FDA approval.

Tinea Versicolor Treatment Market -Regional Analysis

Considering the global scenario of the market, America is the top contributor in this market. The Americas mainly include North America and South America. Due to large amount of money invested in research, clinical trials, and new product development, US is the dominating country in this region.

Europe is the second largest market for tinea versicolor treatment. Germany is dominating this market while UK is the fastest growing tinea versicolor treatment market. Asia Pacific is witnessing rapid growth in this market which is mainly due to rapidly improving healthcare facilities, increasing awareness of disease, and rising healthcare expenditure. Middle East & Africa is expected to have limited growth.

Obtain Report Details with Technological Advancement @ https://www.marketresearchfuture.com/reports/tinea-versicolor-treatment-market-3878

Tinea Versicolor Treatment Market -Key Players

Astellas Pharma US, Inc. (Japan)
Bayer AG (German)
Enzon Pharmaceuticals, Inc. (US)
Galderma S.A. (Switzerland)
Gilead (US)
Novartis AG (Switzerland)
Pfizer Inc. (US)
Taro Pharmaceutical Industries Ltd. (US)
Teva Pharmaceutical Industries Ltd. (Israel)
Valeant (Canada)

Major Points form TOC for Tinea Versicolor Treatment Market Research Report – Forecast to 2023

Chapter 1. Report Prologue

Chapter 2. Market Introduction

Chapter 3. Research Methodology

Chapter 4. Market Dynamics

Chapter 5. Market Factor Analysis

Chapter 6. Global Tinea Versicolor Treatment Market, By Type

Chapter 7. Global Tinea Versicolor Treatment Market, By Treatment

Chapter 8 Global Tinea Versicolor Treatment Market, By End User

Chapter 9. Global Tinea Versicolor Treatment Market, By Region

Chapter 10. Company Landscape

Chapter 11. Company Profiles

Chapter 12. MRFR Conclusion

Chapter 13. Appendix

Get Excusive Discount @ https://www.marketresearchfuture.com/check-discount/3878

About US:

Market Research Future (MRFR), enable customers to unravel the complexity of various industries through Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact Us:

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune - 411028

Maharashtra, India

Phone: +1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Tinea Versicolor Treatment Market Projected to Grow Radiantly By 2023 | Industry Growth Influencer - Astellas Pharma , Inc. , Bayer AG , Enzon Pharmaceuticals, Inc. , Galderma S.A., Gilead, Novartis AG , Pfizer Inc. here

News-ID: 1312719 • Views:

More Releases from Market Research Future

Smart Meters Market to Reach USD 56,854.66 Million by 2035 | CAGR 8.15%
Smart Meters Market to Reach USD 56,854.66 Million by 2035 | CAGR 8.15%
The Smart Meters Market has emerged as a transformative force in the global energy ecosystem, reshaping how utilities and consumers monitor, manage, and optimize electricity, gas, and water consumption. With the rising integration of digital technologies, smart grids, and automation systems, smart meters have become a vital component for enabling real-time data collection, improving operational efficiency, and enhancing overall energy reliability. The market continues to grow rapidly as governments, energy
Solar Hybrid Inverter Market to Expand at 8.90% CAGR Through 2035
Solar Hybrid Inverter Market to Expand at 8.90% CAGR Through 2035
The global Solar Hybrid Inverter Market continues to witness rapid expansion as renewable energy solutions gain traction across residential, commercial, and industrial segments. Hybrid inverters, capable of seamlessly integrating solar PV, batteries, and the grid, have become essential for powering next-generation distributed energy systems. Their ability to optimize energy usage, reduce electricity dependence, and ensure uninterrupted supply has positioned them as a key component of modern solar installations. Get Free Sample
Bifold Doors Industry valued at $10.69 Billion (2024), Expected $18.91 Billion by 2035 | 5.32% CAGR
Bifold Doors Industry valued at $10.69 Billion (2024), Expected $18.91 Billion b …
Bifold Doors Market Overview The Bifold Doors Market is on a growth trajectory, driven by evolving consumer preferences, urbanization, and advancements in design technology. As of 2024, the market is estimated to be valued at approximately $10.69 billion, with projections indicating it will reach around $18.91 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.32% during the forecast period from 2025 to 2035. Get a Sample PDF Brochure of
Waterstop Market Size $2272.36 million in 2024, Projected to Reach $4040.69 million by 2035 at 5.37% CAGR (2025-2035)
Waterstop Market Size $2272.36 million in 2024, Projected to Reach $4040.69 mill …
Overview of the Waterstop Market The Waterstop Market is experiencing significant growth, driven by increasing infrastructure investments and a heightened focus on water management solutions. According to recent analyses, the market was valued at approximately $2272.36 million in 2024 and is projected to reach around $4040.69 million by 2035, with a compound annual growth rate (CAGR) of 5.37% during the forecast period from 2025 to 2035. Get a Sample PDF Brochure of

All 5 Releases


More Releases for Tinea

Foot & Ankle Injuries Fueling Tinea Pedis Market Growth: Pivotal Factor Influenc …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Tinea Pedis Treatment Market Size Growth Forecast: What to Expect by 2025? In recent times, the tinea pedis treatment market has seen robust growth. The market is projected to increase from $1.36 billion in 2024 to $1.45 billion in 2025, with a compound annual growth rate (CAGR) of 6.4%.
Tinea Corporis Market New Product Development & Latest Trends
Tinea Corporis market Size, Status, and Forecast for the 2025-2034. In-depth research has been compiled to provide the most up-to-date information on key aspects of the worldwide market. This research report covers major aspects of the Tinea Corporis Market including drivers, restraints, historical and current trends, regulatory scenarios, and technological advancements. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and supply data (as
Global Onychomycosis (Tinea Unguium) Drug Market
Onychomycosis (Tinea Unguium) Drug Market Forecast 2020-2026 The Global Onychomycosis (Tinea Unguium) Drug Market research report provides and in-depth analysis on industry- and economy-wide database for business management that could potentially offer development and profitability for players in this market. This is a latest report, covering the current COVID-19 impact on the market. The pandemic of Coronavirus (COVID-19) has affected every aspect of life globally. This has brought along several changes
Tinea Corporis Drugs Market Size, Share, Development by 2024
Global Info Research offers a latest published report on Tinea Corporis Drugs Market Analysis and Forecast 2019-2025 delivering key insights and providing a competitive advantage to clients through a detailed report. This report focuses on the key global Tinea Corporis Drugs players, to define, describe and analyze the value, market share, market competition landscape, SWOT analysis and development plans in next few years. To analyze the Tinea Corporis Drugs with respect
Tinea Pedis Treatment Market Dynamic Business Environment during 2017 - 2025
Global Tinea Pedis Treatment Market: Snapshot Athlete's foot known medically as tinea pedis, is a common skin infection of the feet caused by various kinds of fungi. Signs and symptoms often include itching, scaling, cracking and redness. In rare cases, the skin may blister. Athlete's foot fungus may infect any part of the foot, but most often grows between the toes. Apart from these areas, the fungus might develop at the
Tinea Pedis Treatment Market 2017- GSK, Exeltis USA, Valeant
Marketreports.biz, recently published a detailed market research study focused on the "Tinea Pedis Treatment Market" across the global, regional and country level. The report provides 360° analysis of "Tinea Pedis Treatment Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Tinea Pedis Treatment industry, and estimates the future trend of Tinea